Inhibition of beta-amyloid aggregation and neurotoxicity by complementary (antisense) peptides.
about
Sense-antisense (complementary) peptide interactions and the proteomic code; potential opportunities in biology and pharmaceutical science.The Proteomic Code: a molecular recognition code for proteins.Precision active pharmaceutical ingredients are the goal.A simple three-step method for design and affinity testing of new antisense peptides: an example of erythropoietin.
P2860
Inhibition of beta-amyloid aggregation and neurotoxicity by complementary (antisense) peptides.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Inhibition of beta-amyloid agg ...... ementary (antisense) peptides.
@en
type
label
Inhibition of beta-amyloid agg ...... ementary (antisense) peptides.
@en
prefLabel
Inhibition of beta-amyloid agg ...... ementary (antisense) peptides.
@en
P2093
P2860
P1433
P1476
Inhibition of beta-amyloid agg ...... ementary (antisense) peptides.
@en
P2093
Andrew D Miller
Gareth W Roberts
Gary Christie
Jonathan R Heal
P2860
P356
10.1002/1439-7633(20020104)3:1<86::AID-CBIC86>3.0.CO;2-L
P577
2002-01-01T00:00:00Z